Industry: Service & Software
Published Date: 2026-03-06
Pages: 123 Pages
Report ld: 6022575
Request Sample
Customized Report
AI in Medical Imaging and Diagnostics Market Size(US$)

CAGR 2026-2032
20.0%
Market Size,2032
USD 7,752
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global AI in Medical Imaging and Diagnostics market was valued at US$ 2200 million in 2025 and is anticipated to reach US$ 7752 million by 2032, at a CAGR of 20.0% from 2026 to 2032.
AI in Medical Imaging and Diagnostics refers to the use of computer algorithms, machine learning, deep learning, and other technologies to simulate and enhance the diagnostic work of medical professionals, helping doctors make more accurate and faster diagnostic decisions. These AI technologies analyze various forms of medical data, such as medical imaging, electronic health records, genomic data, etc., to identify disease patterns, predict disease progression, and provide personalized treatment recommendations.
The scope of AI products in medical diagnostics includes the following categories:
Medical Imaging Analysis: AI's application in medical imaging analysis is particularly widespread, especially in the processing and interpretation of X-rays, CT scans, MRIs, and ultrasound images. Through deep learning models, AI can automatically detect signs of diseases such as tumors, tuberculosis, and fractures, providing details that might be overlooked by doctors and helping in the early detection of diseases.
Genomics and Precision Medicine: AI plays an important role in the analysis of genomic data. By performing deep learning on DNA sequences, AI can help identify genetic diseases, cancer susceptibility genes, and drug responses, leading to personalized treatment and prevention strategies.
Disease Prediction and Risk Assessment: AI processes big data and uses pattern recognition to predict future health risks of patients. For example, by analyzing a patient's health history, lifestyle, and environmental factors, AI can identify individuals at risk of chronic diseases, heart disease, etc., and offer intervention recommendations.
Intelligent Decision Support Systems: AI-powered decision support systems integrate medical knowledge bases, clinical data, and patient information to assist doctors in making decisions in complex cases, reducing human errors. These systems often incorporate natural language processing (NLP) to extract key information from patients' medical records automatically.
Intelligent Health Monitoring: AI's application in smart devices is increasing, including wearable devices and smart diagnostic tools. These devices monitor patients' physiological indicators, such as heart rate, blood sugar levels, body temperature, etc., in real-time, analyzing health conditions using AI algorithms, and providing predictive health management.
With the continuous development of AI technology, the application of AI in medical diagnostics holds great potential, and the market is growing rapidly. Below is an analysis of the key opportunities and driving factors, risks, market concentration, downstream demand trends, and latest technologies in the AI medical diagnostics market.
Opportunities and Key Drivers:
Technological Advancements: Continuous innovations in AI technologies, particularly in machine learning, deep learning, and natural language processing, have significantly improved the accuracy and efficiency of medical diagnostics. In areas such as medical imaging, genomics analysis, and disease prediction, AI far exceeds traditional methods.
Data Availability: With the digitization of electronic medical records, genomic data, and medical imaging, vast amounts of data are now being effectively utilized, providing rich training data for AI algorithms. These data lay the foundation for optimizing and precisely applying AI systems.
Rising Health Management Demand: With the global aging population and the increase in chronic disease patients, the demand for personalized health management is growing. AI's applications in disease prevention, early detection, and health monitoring can improve overall health levels and reduce healthcare costs.
Risks Facing the Market:
Data Privacy and Security: AI systems need to process large amounts of medical data, which may involve patient privacy. Ensuring data security and compliance, preventing data breaches and misuse, is a significant challenge for AI medical applications.
Trustworthiness and Accuracy: While AI can provide efficient diagnostics, its accuracy still carries some risk. If AI systems fail to account for all potential factors, misdiagnosis or missed diagnoses may occur, affecting patient health and treatment outcomes.
Legal and Ethical Issues: The application of AI in medicine faces legal and ethical challenges. For example, can AI-generated diagnoses be used as a basis for medical decision-making? Who is responsible if an error occurs?
Market Concentration: Currently, the AI medical field is highly concentrated, dominated by large tech companies such as Google, IBM, and Microsoft, which have a leading edge in technology innovation and financial investment. However, as market demand increases, more startups and small to medium-sized companies are emerging in subfields like medical imaging analysis and intelligent health management, creating intense competition.
Downstream Demand Trends:
Early Diagnosis and Prevention: With increasing attention to health management, the demand for AI in early diagnosis and disease prevention is rising. Particularly in early screening for major diseases such as cancer, heart disease, and diabetes, AI plays an increasingly important role.
Personalized Treatment Plans: With the development of precision medicine, AI helps develop personalized treatment and drug selection strategies based on individual genetic and health data. Personalized healthcare will be an essential trend in the future.
Latest Technologies:
Deep Learning and Medical Imaging Analysis: Deep learning technologies are becoming more mature in medical imaging, enabling efficient and accurate detection of tumors, organ abnormalities, and other issues, assisting doctors in fast diagnoses.
Natural Language Processing (NLP) and Clinical Text Analysis: AI uses NLP technologies to automatically extract valuable information from large clinical texts, helping doctors quickly obtain patient history and symptom data during diagnosis.
AI and Robotic Surgery Integration: The integration of AI with robotic surgery technologies will advance surgical procedures, providing higher precision surgical guidance and operations.
This report delivers a comprehensive overview of the global AI in Medical Imaging and Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI in Medical Imaging and Diagnostics. The AI in Medical Imaging and Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global AI in Medical Imaging and Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AI in Medical Imaging and Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI in Medical Imaging and Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI in Medical Imaging and Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Machine Learning Models
1.2.3 Natural Language Processing
1.2.4 Expert Systems
1.2.5 Computer Vision
1.2.6 Robotics
1.3 Market by Application
1.3.1 Global AI in Medical Imaging and Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Medical Imaging
1.3.3 Pathology
1.3.4 Genomic Medicine
1.3.5 Clinical Decision Support Systems
1.3.6 Virtual Health Assistants
1.3.7 Predictive Analytics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI in Medical Imaging and Diagnostics Market Perspective (2021–2032)
2.2 Global AI in Medical Imaging and Diagnostics Growth Trends by Region
2.2.1 Global AI in Medical Imaging and Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AI in Medical Imaging and Diagnostics Historic Market Size by Region (2021–2026)
2.2.3 AI in Medical Imaging and Diagnostics Forecasted Market Size by Region (2027–2032)
2.3 AI in Medical Imaging and Diagnostics Market Dynamics
2.3.1 AI in Medical Imaging and Diagnostics Industry Trends
2.3.2 AI in Medical Imaging and Diagnostics Market Drivers
2.3.3 AI in Medical Imaging and Diagnostics Market Challenges
2.3.4 AI in Medical Imaging and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI in Medical Imaging and Diagnostics Players by Revenue
3.1.1 Global Top AI in Medical Imaging and Diagnostics Players by Revenue (2021–2026)
3.1.2 Global AI in Medical Imaging and Diagnostics Revenue Market Share by Players (2021–2026)
3.2 Global Top AI in Medical Imaging and Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AI in Medical Imaging and Diagnostics Revenue
3.4 Global AI in Medical Imaging and Diagnostics Market Concentration Ratio
3.4.1 Global AI in Medical Imaging and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI in Medical Imaging and Diagnostics Revenue in 2025
3.5 Global Key Players of AI in Medical Imaging and Diagnostics Head Offices and Areas Served
3.6 Global Key Players of AI in Medical Imaging and Diagnostics, Products and Applications
3.7 Global Key Players of AI in Medical Imaging and Diagnostics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AI in Medical Imaging and Diagnostics Breakdown Data by Type
4.1 Global AI in Medical Imaging and Diagnostics Historic Market Size by Type (2021–2026)
4.2 Global AI in Medical Imaging and Diagnostics Forecasted Market Size by Type (2027–2032)
5 AI in Medical Imaging and Diagnostics Breakdown Data by Application
5.1 Global AI in Medical Imaging and Diagnostics Historic Market Size by Application (2021–2026)
5.2 Global AI in Medical Imaging and Diagnostics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AI in Medical Imaging and Diagnostics Market Size (2021–2032)
6.2 North America AI in Medical Imaging and Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AI in Medical Imaging and Diagnostics Market Size by Country (2021–2026)
6.4 North America AI in Medical Imaging and Diagnostics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI in Medical Imaging and Diagnostics Market Size (2021–2032)
7.2 Europe AI in Medical Imaging and Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AI in Medical Imaging and Diagnostics Market Size by Country (2021–2026)
7.4 Europe AI in Medical Imaging and Diagnostics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI in Medical Imaging and Diagnostics Market Size (2021–2032)
8.2 Asia-Pacific AI in Medical Imaging and Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AI in Medical Imaging and Diagnostics Market Size by Region (2021–2026)
8.4 Asia-Pacific AI in Medical Imaging and Diagnostics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI in Medical Imaging and Diagnostics Market Size (2021–2032)
9.2 Latin America AI in Medical Imaging and Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AI in Medical Imaging and Diagnostics Market Size by Country (2021–2026)
9.4 Latin America AI in Medical Imaging and Diagnostics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI in Medical Imaging and Diagnostics Market Size (2021–2032)
10.2 Middle East & Africa AI in Medical Imaging and Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AI in Medical Imaging and Diagnostics Market Size by Country (2021–2026)
10.4 Middle East & Africa AI in Medical Imaging and Diagnostics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM Watson Health
11.1.1 IBM Watson Health Company Details
11.1.2 IBM Watson Health Business Overview
11.1.3 IBM Watson Health AI in Medical Imaging and Diagnostics Introduction
11.1.4 IBM Watson Health Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.1.5 IBM Watson Health Recent Development
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Details
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers AI in Medical Imaging and Diagnostics Introduction
11.2.4 Siemens Healthineers Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.2.5 Siemens Healthineers Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare AI in Medical Imaging and Diagnostics Introduction
11.3.4 GE Healthcare Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.3.5 GE Healthcare Recent Development
11.4 Aidoc
11.4.1 Aidoc Company Details
11.4.2 Aidoc Business Overview
11.4.3 Aidoc AI in Medical Imaging and Diagnostics Introduction
11.4.4 Aidoc Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.4.5 Aidoc Recent Development
11.5 Zebra Medical Vision
11.5.1 Zebra Medical Vision Company Details
11.5.2 Zebra Medical Vision Business Overview
11.5.3 Zebra Medical Vision AI in Medical Imaging and Diagnostics Introduction
11.5.4 Zebra Medical Vision Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.5.5 Zebra Medical Vision Recent Development
11.6 PathAI
11.6.1 PathAI Company Details
11.6.2 PathAI Business Overview
11.6.3 PathAI AI in Medical Imaging and Diagnostics Introduction
11.6.4 PathAI Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.6.5 PathAI Recent Development
11.7 Google Health
11.7.1 Google Health Company Details
11.7.2 Google Health Business Overview
11.7.3 Google Health AI in Medical Imaging and Diagnostics Introduction
11.7.4 Google Health Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.7.5 Google Health Recent Development
11.8 Butterfly Network
11.8.1 Butterfly Network Company Details
11.8.2 Butterfly Network Business Overview
11.8.3 Butterfly Network AI in Medical Imaging and Diagnostics Introduction
11.8.4 Butterfly Network Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.8.5 Butterfly Network Recent Development
11.9 Tempus
11.9.1 Tempus Company Details
11.9.2 Tempus Business Overview
11.9.3 Tempus AI in Medical Imaging and Diagnostics Introduction
11.9.4 Tempus Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.9.5 Tempus Recent Development
11.10 Arterys
11.10.1 Arterys Company Details
11.10.2 Arterys Business Overview
11.10.3 Arterys AI in Medical Imaging and Diagnostics Introduction
11.10.4 Arterys Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.10.5 Arterys Recent Development
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Details
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories AI in Medical Imaging and Diagnostics Introduction
11.11.4 Abbott Laboratories Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.11.5 Abbott Laboratories Recent Development
11.12 Philips Healthcare
11.12.1 Philips Healthcare Company Details
11.12.2 Philips Healthcare Business Overview
11.12.3 Philips Healthcare AI in Medical Imaging and Diagnostics Introduction
11.12.4 Philips Healthcare Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.12.5 Philips Healthcare Recent Development
11.13 Medtronic
11.13.1 Medtronic Company Details
11.13.2 Medtronic Business Overview
11.13.3 Medtronic AI in Medical Imaging and Diagnostics Introduction
11.13.4 Medtronic Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.13.5 Medtronic Recent Development
11.14 Canon Medical Systems
11.14.1 Canon Medical Systems Company Details
11.14.2 Canon Medical Systems Business Overview
11.14.3 Canon Medical Systems AI in Medical Imaging and Diagnostics Introduction
11.14.4 Canon Medical Systems Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.14.5 Canon Medical Systems Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Details
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson AI in Medical Imaging and Diagnostics Introduction
11.15.4 Johnson & Johnson Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.15.5 Johnson & Johnson Recent Development
11.16 Nuance Communications
11.16.1 Nuance Communications Company Details
11.16.2 Nuance Communications Business Overview
11.16.3 Nuance Communications AI in Medical Imaging and Diagnostics Introduction
11.16.4 Nuance Communications Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.16.5 Nuance Communications Recent Development
11.17 Veeva Systems
11.17.1 Veeva Systems Company Details
11.17.2 Veeva Systems Business Overview
11.17.3 Veeva Systems AI in Medical Imaging and Diagnostics Introduction
11.17.4 Veeva Systems Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.17.5 Veeva Systems Recent Development
11.18 Babylon Health
11.18.1 Babylon Health Company Details
11.18.2 Babylon Health Business Overview
11.18.3 Babylon Health AI in Medical Imaging and Diagnostics Introduction
11.18.4 Babylon Health Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.18.5 Babylon Health Recent Development
11.19 AliveCor
11.19.1 AliveCor Company Details
11.19.2 AliveCor Business Overview
11.19.3 AliveCor AI in Medical Imaging and Diagnostics Introduction
11.19.4 AliveCor Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.19.5 AliveCor Recent Development
11.20 Health Catalyst
11.20.1 Health Catalyst Company Details
11.20.2 Health Catalyst Business Overview
11.20.3 Health Catalyst AI in Medical Imaging and Diagnostics Introduction
11.20.4 Health Catalyst Revenue in AI in Medical Imaging and Diagnostics Business (2021–2026)
11.20.5 Health Catalyst Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global AI in Medical Imaging and Diagnostics market size was US$ 2200 million in 2025 and is forecast to reach a readjusted size of US$ 7752 million by 2032 with a CAGR of 20.0% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 109
USD 4250.00
(Single User License)
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ 2200 million in 2025 and is projected to reach US$ 7752 million, growing at a CAGR of 20.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 139
USD 3950.00
(Single User License)
The global AI in Medical Imaging and Diagnostics market is projected to grow from US$ 1800 million in 2024 to US$ 6569 million by 2031, at a CAGR of 20.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 151
USD 4900.00
(Single User License)
The global AI in Medical Imaging and Diagnostics market size was US$ 1800 million in 2024 and is forecast to a readjusted size of US$ 6569 million by 2031 with a CAGR of 20.0% during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 104
USD 4250.00
(Single User License)
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ 1800 million in 2024 and is forecast to a readjusted size of US$ 6569 million by 2031 with a CAGR of 20.0% during the forecast period 2025-2031.
Published Date: 2025-02-22
Pages: 140
USD 3950.00
(Single User License)
Valued at US$ 2200 million in 2024, the global AI in Medical Imaging and Diagnostics market is forecast to reach US$ 6569 million by 2030, at a CAGR of 20.0% during the forecast period.
Published Date: 2025-02-22
Pages: 150
USD 4900.00
(Single User License)
The global market for AI in Medical Imaging and Diagnostics was valued at US$ 1800 million in the year 2024 and is projected to reach a revised size of US$ 6569 million by 2031, growing at a CAGR of 20.0% during the forecast period.
Published Date: 2025-02-22
Pages: 96
USD 2900.00
(Single User License)
Market Analysis and Insights: Global AI in Medical Imaging and Diagnostics Market
Published Date: 2024-04-12
Pages: 114
USD 4900.00
(Single User License)
The global AI in Medical Imaging and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 94
USD 2900.00
(Single User License)
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-07
Pages: 124
USD 3950.00
(Single User License)
The global AI in Medical Imaging and Diagnostics market size was US$ 2200 million in 2025 and is forecast to reach a readjusted size of US$ 7752 million by 2032 with a CAGR of 20.0% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 109
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ 2200 million in 2025 and is projected to reach US$ 7752 million, growing at a CAGR of 20.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 139
The global AI in Medical Imaging and Diagnostics market is projected to grow from US$ 1800 million in 2024 to US$ 6569 million by 2031, at a CAGR of 20.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 151
The global AI in Medical Imaging and Diagnostics market size was US$ 1800 million in 2024 and is forecast to a readjusted size of US$ 6569 million by 2031 with a CAGR of 20.0% during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 104
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ 1800 million in 2024 and is forecast to a readjusted size of US$ 6569 million by 2031 with a CAGR of 20.0% during the forecast period 2025-2031.
Published: 2025-02-22
Pages: 140
Valued at US$ 2200 million in 2024, the global AI in Medical Imaging and Diagnostics market is forecast to reach US$ 6569 million by 2030, at a CAGR of 20.0% during the forecast period.
Published: 2025-02-22
Pages: 150
The global market for AI in Medical Imaging and Diagnostics was valued at US$ 1800 million in the year 2024 and is projected to reach a revised size of US$ 6569 million by 2031, growing at a CAGR of 20.0% during the forecast period.
Published: 2025-02-22
Pages: 96
Market Analysis and Insights: Global AI in Medical Imaging and Diagnostics Market
Published: 2024-04-12
Pages: 114
The global AI in Medical Imaging and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 94
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-07
Pages: 124
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now